Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*-Reference-Cited by-同舟云学术

Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*

Published:2016-10-31 Issue:3 Volume:56 Page:384-390
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Huguet Florence¹²,Hajj Carla²,Winston Corrine B.³,Shi Weiji⁴,Zhang Zhigang⁴,Wu Abraham J.²,O’Reilly Eileen M.⁵,Reidy Diane L.⁵,Allen Peter⁶,Goodman Karyn A.⁷

Affiliation:

1. Department of Radiation Oncology, Tenon Hospital, Hôpitaux Universitaires Est Parisien, University Pierre and Marie Curie Paris VI, Paris, France;

2. Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

3. Department of Radiology at Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

4. Department of Biostatistics at Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

5. Department of Medical Oncology at Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

6. Department of Surgery at Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

7. Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA

Funder

The study was supported by a grant from Nuovo-Soldati Foundation for Cancer Research

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2016.1245862

Reference28 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

3. Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

4. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

5. A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?;Cancers;2024-06-30

2. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma;American Journal of Clinical Oncology;2023-12-22

3. Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation;International Journal of Radiation Oncology*Biology*Physics;2022-11

4. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer;Radiotherapy and Oncology;2022-10

5. Radiothérapie hypofractionnée extrême du cancer du pancréas;Cancer/Radiothérapie;2021-10